Reduced endothelial secretion and plasma levels of transforming growth factor-β1 in patients with hereditary hemorrhagic telangiectasia type 1

Cardiovascular Research

Volumn 68, Issue 1, 2005, Pages 155-164

  Letarte, Michelle ^a,b   McDonald, Merry Lynn ^a,c   Li, Chenggang ^d   Kathirkamathamby, Kirishanthy ^a   Vera, Sonia ^a   Pece Barbara, Nadia ^a,e   Kumar, Shant ^d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Cytokines; Endothelial factors; Endothelial receptors; Hemostasis; Signal transduction

Indexed keywords

ENDOGLIN; MESSENGER RNA; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; METABOLISM; MONOCYTE; MUTATION; NEWBORN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; RENDU OSLER WEBER DISEASE; UMBILICAL VEIN; WESTERN BLOTTING;

ANTIGENS, CD; CASE-CONTROL STUDIES; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOPRECIPITATION; INFANT, NEWBORN; MUTATION; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMAD PROTEINS, RECEPTOR-REGULATED; STATISTICS, NONPARAMETRIC; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; TRANSFORMING GROWTH FACTOR BETA; UMBILICAL VEINS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 24344461857     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.04.028     Document Type: Article

References (40)

1. A.E. Guttmacher, D.A. Marchuk, and R.I.J. White Hereditary hemorrhagic telangiectasia N Engl J Med 333 1995 918 924
2. C. Shovlin, and M. Letarte Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms Thorax 54 1999 714 729
3. K.A. McAllister, K.M. Grogg, D.W. Johnson, C.J. Gallione, M.A. Baldwin, and C.E. Jackson Endoglin, a TGF-β binding protein of endothelial cells is the gene for hereditary haemorrhagic telangiectasia type 1 Nat Genet 8 1994 345 351
4. J.N. Berg, C.J. Gallione, T.T. Stenzel, D.W. Johnson, W.P. Allen, and C.E. Schwartz The activin receptor-like kinase 1 gene: genetic structure and mutations in hereditary hemorrhagic telangiectasia type 2 Am J Hum Genet 6 1997 60 67
5. P. Bayrack-Toydemir, R. Mao, S. Lewin, and J. McDonald Hereditary hemorrhagic telangiectasia: an overview of diagnosis and management in the molecular era for clinicians Genet Med 6 2004 175 191
6. S. Cheifetz, T. Bellón, C. Calés, S. Vera, C. Bernabeu, and J. Massagué Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells J Biol Chem 267 1992 19027 19030
7. J. Massague TGF-beta signal transduction Annu Rev Biochem 67 1998 753 791
8. A. Nakao, T. Imamura, S. Souchelnytskyi, M. Kawabata, A. Ishisaki, and E. Oeda TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4 EMBO J 16 1997 5353 5362
9. S.P. Oh, T. Seki, K.A. Goss, T. Imamura, Y. Yi, and P.K. Donahoe Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis Proc Natl Acad Sci U S A 97 2000 2626 2631
10. M.J. Goumans, G. Valdimarsdottir, S. Itoh, F. Lebrin, J. Larsson, and C. Mummery Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling Mol Cell 12 2003 817 828
11. M.J. Goumans, F. Lebrin, and G. Valdimarsdottir Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways Trends Cardiovasc Med 13 2003 301 307
12. A. Bourdeau, D.J. Dumont, and M. Letarte A murine model of hereditary hemorrhagic telangiectasia J Clin Invest 104 1999 1343 1351
13. S. Srinivasan, M.A. Hanes, T. Dickens, M.E.M. Porteous, S.P. Oh, and L.P. Hale A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2 Hum Mol Genet 12 2003 473 482
14. D.Y. Li, L.K. Sorensen, B.S. Broooke, L.D. Urness, E.C. Davis, and D.G. Taylor Defective angiogenesis in mice lacking endoglin Science 284 1999 1534 1537
15. A. Bourdeau, M. Faughan, M.L. McDonald, A.D. Paterson, I.R. Wanless, and M. Letarte Potential role of modifier genes influencing TGF-β1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia Am J Pathol 158 2001 2011 2020
16. M. Jerkic, J.V. Rivas-Elena, M. Prieto, R. Carron, F. Sanz-Rodriguez, and F. Perez-Barriocanal Endoglin regulates nitric oxide-dependent vasodilatation FASEB J 18 2004 609 611
17. C.L. Shovlin, A.E. Guttmacher, E. Buscarini, M.E. Faughnan, R.H. Hyland, and C.J. Westermann Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome) Am J Med Genet 91 2000 66 67 [in process citation]
18. U. Cymerman, S. Vera, N. Pece-Barbara, A. Bourdeau, R.I. White Jr., and J. Dunn Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin Pediatr Res 47 2000 24 35
19. U. Cymerman, S. Vera, A. Karabegovic, S. Abdalla, and M. Letarte Characterization of 17 novel endoglin mutations associated with hereditary hemorrhagic telangiectasia Hum Mut 21 2003 482 492
20. N. Pece, S. Vera, U. Cymerman, R.I.J. White, J.L. Wrana, and M. Letarte Mutant endoglin in hereditary hemorrhagic telangiectasia type I is transiently expressed intracellularly and is not a dominant negative J Clin Invest 100 1997 2568 2579
21. N. Pece-Barbara, U. Cymerman, S. Vera, D.A. Marchuk, and M. Letarte Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1 Hum Mol Genet 8 1999 2171 2181
22. C. Li, B. Guo, P.B. Wilson, A. Stewart, G. Byrne, and N. Bundred Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer Int J Cancer 89 2000 122 126 [in process citation]
23. M.E. Paquet, N. Pece-Barbara, S. Vera, U. Cymerman, A. Karabegovic, and C. Shovlin Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function Hum Mol Genet 10 2001 1347 1357
24. S.A. Abdalla, U. Cymerman, D. Rushlow, N. Chen, G.P. Stoeber, and E.G. Lemire Novel mutations and polymorphisms in genes causing hereditary hemorrhagic telangiectasia Hum Mut 25 2005 320 321
25. A. Bourdeau, M.E. Faughnan, and M. Letarte Endoglin-deficient mice, a unique model to study hereditary hemorrhagic telangiectasia Trends Cardiovasc Med 10 2000 279 285
26. F. Lebrin, M.J. Goumans, L. Jonker, R.L. Carvalho, G. Valdimarsdottir, and M. Thorikay Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction EMBO J 23 2004 4018 4028
27. F.J. Blanco, J.F. Santibanez, M. Guerrero-Esteo, C. Langa, C.P. Vary, and C. Bernabeu Interaction and functional interplay between endoglin and ALK1, two components of the endothelial transforming growth factor-beta receptor complex J Cell Physiol 2005
28. A.B. Roberts, and M.B. Sporn Physiological actions and clinical applications of transforming growth factor-β (TGF-β) Growth Factors 8 1993 1 9
29. A.B. Roberts Molecular and cell biology of TGF-β Miner Electrolyte Metab 24 1998 111 119
30. P.-E. Gleizes, J.S. Munger, I. Nunes, J.G. Harpel, R. Mazzieri, and I. Noguera TGF-β latency: biological significance and mechanisms of activation Stem Cells 15 1997 190 197
31. G.S. Ashcroft, X. Yang, A.B. Glick, M. Weinstein, J.L. Letterio, and D.E. Mizel Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response Nat Cell Biol 1 1999 260 266
32. E. Van Obberghen-Schilling, N.S. Roche, K.C. Flanders, M.B. Sporn, and A.B. Roberts Transforming growth factor β1 positively regulates its own expression in normal and transformed cells J Biol Chem 263 1988 7741 7746
33. J.-J. Ventura, N.J. Kennedy, R.A. Flavell, and R.J. Davis JNK regulates autocrine expression of TGF-β1 Mol Cell 15 2004 269 278
34. R.L.C. Carvalho, L. Jonker, M.-J. Goumans, J. Larrson, P. Bouwman, and S. Karlsson Defective paracrine signalling by TGF-β in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary hemorrhagic telangiectasia Development 131 2004 6237 6247
35. C. Li, H. Bethell, P.B. Wilson, D. Bhatnagar, M.G. Walker, and S. Kumar The significance of CD105, TGF β and CD105/TGF β complexes in coronary artery disease Atherosclerosis 152 2000 249 256
36. A. Bourdeau, U. Cymerman, M.E. Paquet, W. Meschino, W.C. McKinnon, and A.E. Guttmacher Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1 Am J Pathol 156 2000 911 923
37. S.A. Abdalla, U. Cymerman, R.M. Johnson, C.M. Deber, and M. Letarte Disease-associated mutations in conserved residues of ALK1 kinase domain Eur J Hum Genet 11 2003 279 287
38. N.L.M. Chan, A. Bourdeau, S. Vera, S. Abdalla, M. Gross, and J. Wong Umbilical vein and placental vessels from newborns with hereditary hemorrhagic telangiectasia type 1 genotype are normal despite reduced expression of endoglin Placenta 25 2004 208 217
39. P.A. Frischmeyer, and H.C. Dietz Nonsense-mediated mRNA decay in health and disease Hum Mol Genet 8 1999 1893 1900
40. F. Sanz-Rodriguez, A. Fernandez-Lopez, R. Zarrabeitia, A. Perez-Molino, J.R. Ramirez, and E. Coto Mutation analysis in Spanish patients with hereditary hemorrhagic telangiectasia: deficient endoglin up-regulation in activated monocytes Clin Chem 50 2004 2003 2111